Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
RNA Analysis/ Transcriptomics Global Market Report 2025 Including: 1) By Product: Reagents/Consumables; Instruments; Software 2) By Technology; Microarrays; Sequencing; Polymerase Chain Reaction RNA Interference 3) By Application: Clinical Diagnostics; Drug Discovery; Toxicogenomics; Comparative Transcriptomics; RNA Interference Covering: Affymetrix Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Illumina Inc.
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033
... growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market. ... Read More
-
Japan Proteomics Market Assessment, By Products and Services [Instruments, Reagents and Consumables, Services], By Technology [Spectrometry, Electrophoresis, Chromatography, Microarray Instruments, X-Ray Crystallography, Next-Generation Sequencing, Protein Fractionation Systems, Surface Plasma Resonance Systems, Others], By Application [Drug Discovery and Development, Disease Diagnosis, Others], By End-user [Academic and Research Institutes, Clinical Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, FY2018-FY2032F
... population, increasing investments in the healthcare sector, and rising requirements for advanced diagnostic technologies are some of the factors propelling the growth of the proteomics market in Japan. Proteomics is witnessing significant growth in the ... Read More
-
Cell-based Assay Market Report by Product and Services (Consumables, Instruments, Services, Software), Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, and Others), Application (Drug Discovery, Basic Research, ADME Studies, Predictive Toxicology, and Others), End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutions, Contract Research Organizations, and Others), and Region 2025-2033
... The growing demand for novel therapies to address various diseases, rising focus on personalized medicines, and innovations in cell culture technologies to improve the accuracy of drug screening are some of the major factors propelling ... Read More
-
Mass Spectrometry Market by Product (Instrument (Triple Quadrupole, Q-TOF, FTMS, Quadrupole, TOF), Software & Services), Sample (LC-MS, GC-MS), Application (Omics, Drug Discovery, Food, Environmental), End User (Pharma, Biotech) - Global Forecasts to 2030
... to mass spectrometers' applications in environmental sample testing of analytes like PFAS and microplastics in environmental testing which are expected to increase. The pharmaceutical industry's allocation of larger budgets for research and development and government ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Peptide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... investments and substantial funding for genomics and proteomics research are driving the demand for peptides in drug discovery and therapeutic development. Owing to the rising demand for effective protein-based drugs for the proper treatment process, ... Read More
-
Drug Discovery Informatics
... at a CAGR of 9.6% over the analysis period 2024-2030. Drug Discovery Informatics Software, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.4 Billion by the ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Peptide Synthesis Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Label-free Array Systems
... at a CAGR of 5.6% over the analysis period 2024-2030. Surface Plasmon Resonance (SPR) Technology, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.8 Billion by ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
Immunomodulators
... 5.7% over the analysis period 2024-2030. Immunosuppressants, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$209.8 Million by the end of the analysis period. Growth in ... Read More
-
Live Cell Encapsulation
... at a CAGR of 3.8% over the analysis period 2024-2030. Alginate Polymer, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of ... Read More
-
Pathology Instruments
... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
Organs-on-Chips
... 35.3% over the analysis period 2024-2030. Liver-on-a- Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth ... Read More
-
Single-Use Bioprocessing
... CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end ... Read More
-
MRSA Drugs
... CAGR of 4.5% over the analysis period 2024-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end of the ... Read More
-
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & marketing, Drug Safety), End User (Pharma, Medical Device), & Region - Global Forecast to 2029
... grow as a result of the heterogenity & complexity of big data in life sciences, surging demand for technologically advanced analytical solutions for various applications across the industry, such as, research & development, commercialization (market ... Read More
-
Drug Discovery Outsourcing
... at a CAGR of 6.5% over the analysis period 2024-2030. Lead Identification & Candidate Optimization Workflow, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.0 Billion ... Read More
-
Artificial Intelligence (AI) in Drug Discovery
... reach US$13.5 Billion by 2030, growing at a CAGR of 26.4% over the analysis period 2024-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and ... Read More
-
Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029
... to grow as a result of the increasing demand for personalized therapies and precision medicines, and the growing applications of AI in epidemiological models for predicting disease outbreaks. It helps public health officials to respond ... Read More
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
... the drug development process has been one of the major drivers in the adoption of biosimulation tools. These tools predict how the drugs will behave inside the human body, potentially minimizing the requirements of extensive ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Hepatitis C Treatment
... at a CAGR of 10.7% over the analysis period 2024-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$25.3 Billion by the end ... Read More
-
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment
... Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Medication Treatment, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$5.5 Billion ... Read More
Research Assistance
